Al Hammadi Holding Company (TADAWUL:4007)

Market Cap	4.48B -27.1%
Revenue (ttm)	1.25B +6.2%
Net Income	224.17M -35.7%
EPS	1.40 -35.7%
Shares Out	160.00M
PE Ratio	19.98
Forward PE	16.10
Dividend	0.80 (2.86%)
Ex-Dividend Date	Jun 2, 2026

Volume	50,829
Open	28.02
Previous Close	28.20
Day's Range	27.92 - 28.20
52-Week Range	23.42 - 38.80
Beta	0.01
Analysts	Buy
Price Target	37.47 (+33.82%)
Earnings Date	Aug 6, 2026

About TADAWUL:4007

Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. The company offers inpatient and outpatient hospital services, including accommodation, medical professional services, equipment, radiology, laboratory, and bundled healthcare offerings; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4007

Financial Performance

In 2025, TADAWUL:4007's revenue was 1.23 billion, an increase of 6.99% compared to the previous year's 1.15 billion. Earnings were 241.86 million, a decrease of -28.61%.

Analyst Summary

According to 7 analysts, the average rating for 4007 stock is "Buy." The 12-month stock price target is SAR 37.47, which is an increase of 33.82% from the latest price.

Price Target

SAR 37.47

(33.82% upside)

Analyst Consensus: Buy